1. Home
  2. JXG vs PFSA Comparison

JXG vs PFSA Comparison

Compare JXG & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

HOLD

Current Price

$7.91

Market Cap

11.4M

Sector

N/A

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.12

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JXG
PFSA
Founded
N/A
2009
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
11.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JXG
PFSA
Price
$7.91
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
203.8K
10.7M
Earning Date
05-14-2026
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.26
N/A
Revenue
$46,835,624.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.54
N/A
Revenue Growth
21.68
122.22
52 Week Low
$3.01
$0.07
52 Week High
$73.80
$12.76

Technical Indicators

Market Signals
Indicator
JXG
PFSA
Relative Strength Index (RSI) 60.94 N/A
Support Level $8.44 N/A
Resistance Level $10.00 N/A
Average True Range (ATR) 1.62 0.00
MACD -0.15 0.00
Stochastic Oscillator 51.03 0.00

Price Performance

Historical Comparison
JXG
PFSA

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: